RS20060086A - Antagonistic analogs of gh-rh(2003) - Google Patents

Antagonistic analogs of gh-rh(2003)

Info

Publication number
RS20060086A
RS20060086A YUP-2006/0086A YUP20060086A RS20060086A RS 20060086 A RS20060086 A RS 20060086A YU P20060086 A YUP20060086 A YU P20060086A RS 20060086 A RS20060086 A RS 20060086A
Authority
RS
Serbia
Prior art keywords
analogs
inhibit
hgh
antagonistic analogs
antagonistic
Prior art date
Application number
YUP-2006/0086A
Other languages
English (en)
Inventor
Andrew V. Schally
Jozsef Varga
Marta Zarandi
Ren Zhi Cai
Original Assignee
The Administrattors Of The Tulane Educational Fund (A Not For Profit Corporation)
The United States Of America Represented By The Department Of Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Administrattors Of The Tulane Educational Fund (A Not For Profit Corporation), The United States Of America Represented By The Department Of Veterans Affairs filed Critical The Administrattors Of The Tulane Educational Fund (A Not For Profit Corporation)
Publication of RS20060086A publication Critical patent/RS20060086A/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Obezbeđene su nove serije sintetskih analoga antagonista hGH-RH(1-29)NH2• Ovi analozi inhibiraju aktivnost endogenog hGH-RH na receptore za GH-RH hipofize i time sprečavaju oslobađanje hormona rasta. Analozi, takođe, inhibiraju proliferaciju humanih kancera preko direktnog dejstva na kancerske ćelije. Veće inhibitorne mogućnosti novih analoga u poređenju sa prethodno opisanim, dobijene su zamenom raznih aminokiselina.
YUP-2006/0086A 2003-08-05 2004-07-26 Antagonistic analogs of gh-rh(2003) RS20060086A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49270603P 2003-08-05 2003-08-05
PCT/US2004/024183 WO2005016953A2 (en) 2003-08-05 2004-07-26 Antagonistic analogs of gh-rh (2003)

Publications (1)

Publication Number Publication Date
RS20060086A true RS20060086A (en) 2008-08-07

Family

ID=34193144

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2006/0086A RS20060086A (en) 2003-08-05 2004-07-26 Antagonistic analogs of gh-rh(2003)

Country Status (19)

Country Link
US (1) US7452865B2 (sr)
EP (1) EP1651662A4 (sr)
JP (1) JP2007526900A (sr)
KR (1) KR20060088875A (sr)
CN (1) CN1871020A (sr)
AR (1) AR049149A1 (sr)
AU (1) AU2004265280A1 (sr)
BR (1) BRPI0413257A (sr)
CA (1) CA2534436A1 (sr)
IL (1) IL173201A0 (sr)
MX (1) MXPA06001369A (sr)
NO (1) NO20061060L (sr)
PL (1) PL380437A1 (sr)
RS (1) RS20060086A (sr)
RU (1) RU2335506C2 (sr)
SG (1) SG136958A1 (sr)
TW (1) TW200517400A (sr)
WO (1) WO2005016953A2 (sr)
ZA (1) ZA200600966B (sr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009108364A2 (en) * 2008-02-27 2009-09-03 Ipsen Pharma S.A.S. Antagonistic analogues of ghrh
US8691942B2 (en) 2008-03-28 2014-04-08 University Of Miami N- and C- terminal substituted antagonistic analogs of GH-RH
AU2009228244A1 (en) * 2008-03-28 2009-10-01 The United States Of America Represented By The United States Department Of Veteran's Affairs Novel N-and C-terminal substituted -antagonistic analogs of human GH-RH
EP3590956A1 (en) * 2008-06-12 2020-01-08 Ipsen Bioinnovation Limited Suppression of neuroendocrine diseases
JP5799397B2 (ja) 2008-06-12 2015-10-28 イプセン・バイオイノベーション・リミテッドＩｐｓｅｎ Ｂｉｏｉｎｎｏｖａｔｉｏｎ Ｌｉｍｉｔｅｄ 癌の抑制
US8796216B2 (en) 2008-06-12 2014-08-05 Syntaxin Limited Suppression of neuroendocrine diseases
US8227421B2 (en) 2009-09-17 2012-07-24 University Of Miami Fluorinated GHRH antagonists
WO2011153491A2 (en) 2010-06-03 2011-12-08 University Of Miami Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets
MX2013012259A (es) 2011-04-21 2013-11-22 Theratechnologies Inc Analogos del factor de liberacion de la hormona de crecimiento (grf) y usos de estos.
US9079974B2 (en) 2011-12-21 2015-07-14 The University Of Miami GH-RH analogs with potent agonistic effects
WO2014004934A2 (en) * 2012-06-27 2014-01-03 University Of Miami Compositions and methods of treating alzheimer's disease
WO2014100809A2 (en) 2012-12-21 2014-06-26 University Of Miami Ghrh agonists for the treatment of ischemic disorders
EP2935317B1 (en) 2012-12-21 2019-03-27 University of Miami Ghrh agonists for islet cell transplantation and function and the treatment of diabetes
AU2020218272A1 (en) 2019-02-08 2021-09-02 United States Government As Represented By The Department Of Veterans Affairs Growth hormone-releasing hormone antagonists and uses thereof
CA3178840A1 (en) 2020-04-27 2021-11-04 The University Of Miami Method of treating an inflammatory disorder
CN114195881B (zh) * 2021-12-16 2022-09-16 浙江湃肽生物股份有限公司 一种制备醋酸舍莫瑞林的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942489A (en) * 1996-05-03 1999-08-24 The Administrators Of The Tulane Educational Fund HGH-RH(1-29)NH2 analogues having antagonistic activity
US6057422A (en) * 1998-11-25 2000-05-02 The Administrators Of The Tulane Educational Fund Antagonistic analogs of GH-RH inhibiting IGF-I and -II

Also Published As

Publication number Publication date
EP1651662A2 (en) 2006-05-03
RU2335506C2 (ru) 2008-10-10
SG136958A1 (en) 2007-11-29
WO2005016953A3 (en) 2006-02-09
CN1871020A (zh) 2006-11-29
AU2004265280A1 (en) 2005-02-24
ZA200600966B (en) 2007-05-30
CA2534436A1 (en) 2005-02-24
BRPI0413257A (pt) 2006-10-03
TW200517400A (en) 2005-06-01
PL380437A1 (pl) 2007-01-22
NO20061060L (no) 2006-05-03
WO2005016953A2 (en) 2005-02-24
JP2007526900A (ja) 2007-09-20
EP1651662A4 (en) 2009-07-01
US20070042950A1 (en) 2007-02-22
RU2006106701A (ru) 2007-09-20
KR20060088875A (ko) 2006-08-07
IL173201A0 (en) 2006-06-11
US7452865B2 (en) 2008-11-18
MXPA06001369A (es) 2007-02-19
AR049149A1 (es) 2006-07-05

Similar Documents

Publication Publication Date Title
TW200517400A (en) Antagonistic analogs of GH-RH (2003)
TR199701356A2 (xx) L�kozit adhasyonu inhibit�rleri ve VLA-4-antagonistleri olarak heterosiklenler.
MY138258A (en) Growth hormone secretagogues
MX9500072A (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
DE60045524D1 (de) Ein Huhn GnRH-II Analog zur Verwendung in der Reduktion des Tumorzellwachstums
AP9801312A0 (en) 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor anatagonist.
CO5280048A1 (es) Agonistas del receptor 3 (r3) del peptido activador de la adenilato ciclasa de la pituitaria
ATE78831T1 (de) Biologisch wirksame lysin enthaltende octapeptide.
EA200600190A1 (ru) Производные пиримидин-2,4-диона в качестве антагонистов рецептора гонадотропин-высвобождающего гормона
GEP20084487B (en) Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof
BG105205A (en) Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
MX9705710A (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
PL315114A1 (en) Compounds exhibiting properties of releasing growth hormones
EP1233013A4 (en) phenylalanine derivatives
BG105638A (en) Antagonist analogs of gh-rh inhibiting igf-i and -ii
WO2009120831A3 (en) Novel n-and c-terminal substituted -antagonistic analogs of human gh-rh
CO5140111A1 (es) Tratamiento de tumores mediante la administracion de compuestos que induce la liberacion de la hormona de crecimiento y sus antagonistas
BG106008A (en) Novel lhrh antagonists with improved solubility characteristics
TW200501963A (en) Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
EP0973518A4 (en) SEMI-SYNTHETIC PROCESSES FOR THE PREPARATION OF DIDEMNINE ANALOGS
UA66817C2 (uk) Збиральна машина
WO2009108364A3 (en) Antagonistic analogues of ghrh
SG146692A1 (en) Melanin concentrating hormone antagonists
AU2003220441A8 (en) Dipeptidic growth hormone secretagogues